TrialDiabetologia2023

Pen-administered low-dose dasiglucagon vs usual care for prevention and treatment of non-severe hypoglycaemia in people with type 1 diabetes during free-living conditions: a Phase II, randomised, open-label, two-period crossover trial.

Christian Laugesen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.